Sovereign impact metrics.
What a domestic supply chain returns: access, resilience, and a high-skill economy.
Three mandates, one site.
National health security, regional industrial capability and global immunisation equity are usually pursued by three different institutions. Adjuvant Bio was built where they overlap, which is what makes the capital case work.
Three returns on sovereign supply.
Health security
Essential medicines that cannot be cut off at a border during a crisis.
Economic diversification
High-value manufacturing and a research base that compounds over time.
Talent & knowledge
A generation of scientists and operators trained on a world-class platform.
Strategic initiatives.
Pandemic response reserve
Standing capacity held in reserve for rapid conversion to outbreak response, validated and audit-ready.
- 100-day response readiness
- Multi-modality platform
- Pre-negotiated supply agreements
Biotech talent accelerator
A training pipeline that turns graduates into GMP-ready process scientists and operators.
- Sterile-operations programme
- University research partnerships
- Apprenticeship to leadership tracks
See the pipeline behind the numbers.
Every metric here traces back to programmes in development.